Statements (58)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:approves |
gptkb:2006
gptkb:FDA |
| gptkbp:brand |
gptkb:Kariva
|
| gptkbp:can_be |
gptkb:skincare_product
polycystic ovary syndrome menstrual regulation |
| gptkbp:clinical_trial |
studies on efficacy
studies on safety studies on drug interactions studies on side effects |
| gptkbp:contains |
gptkb:ethinyl_estradiol
desogestrel |
| gptkbp:contraindication |
liver disease
certain cancers history of blood clots smoking over age 35 |
| gptkbp:dosage_form |
oral
28 tablets per pack |
| gptkbp:duration |
monthly
|
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Kariva
|
| gptkbp:ingredients |
gptkb:ethinyl_estradiol
desogestrel |
| gptkbp:interacts_with |
gptkb:St._John's_Wort
antibiotics anticonvulsants HIV medications |
| gptkbp:is_available_in |
generic form
|
| gptkbp:is_effective_against |
over 99% with perfect use
91% with typical use |
| gptkbp:is_monitored_by |
blood pressure
cholesterol levels |
| gptkbp:is_used_by |
gptkb:philosopher
|
| gptkbp:is_used_for |
contraception
|
| gptkbp:manufacturer |
gptkb:Teva_Pharmaceuticals
|
| gptkbp:marketed_as |
various brand names
|
| gptkbp:packaging |
blister pack
|
| gptkbp:population |
available online
includes dosage instructions includes contraindications includes side effects provided by pharmacies |
| gptkbp:requires |
gptkb:theorem
|
| gptkbp:side_effect |
headache
nausea breast tenderness mood changes |
| gptkbp:suitable_for |
pregnant women
breastfeeding women women over 35 who smoke women with certain health conditions |
| gptkbp:symptoms |
weight gain
mood swings breast tenderness irregular periods |
| gptkbp:bfsParent |
gptkb:ethinylestradiol
|
| gptkbp:bfsLayer |
6
|